Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Docetaxel and Prednisone (CRPC)
This study is ongoing, but not recruiting participants.
Study NCT01234025   Information provided by Isis Pharmaceuticals

First Received on November 2, 2010.   Last Updated on November 1, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial